Topics

Allegro Ophthalmics to Present the Results of Its ALG-1007 Ex-U.S. Trial for Dry Eye Disease at the 2019 ASCRS•ASOA Annual Meeting

11:00 EDT 30 Apr 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
ALG-1007 Marks Allegro’s Second Exploratory Anti-Integrin Drug Candidate—Now, for the Potential Treatment of Dry Eye Disease Following last week’s news that the company is expanding its pipeline into dry eye and has cr...

Other Sources for this Article

MEDIA CONTACT:
Michele Gray
Gray Communications, LLC
(917) 449-9250
michele_gray@me.com

NEXT ARTICLE

More From BioPortfolio on "Allegro Ophthalmics to Present the Results of Its ALG-1007 Ex-U.S. Trial for Dry Eye Disease at the 2019 ASCRS•ASOA Annual Meeting"

Quick Search

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...